2023
DOI: 10.3390/pharmaceutics15020326
|View full text |Cite
|
Sign up to set email alerts
|

pH-Responsive Hybrid Nanoassemblies for Cancer Treatment: Formulation Development, Optimization, and In Vitro Therapeutic Performance

Abstract: Current needs for increased drug delivery carrier efficacy and specificity in cancer necessitate the adoption of intelligent materials that respond to environmental stimuli. Therefore, we developed and optimized pH-triggered drug delivery nanoassemblies that exhibit an increased release of doxorubicin (DOX) in acidic conditions typical of cancer tissues and endosomal vesicles (pH 5.5) while exhibiting significantly lower release under normal physiological conditions (pH 7.5), indicating the potential to reduce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 66 publications
0
5
0
Order By: Relevance
“…A stability study was performed to determine whether these magneto-plasmonic elastic liposomes satisfy the requirements for commercial and clinical outcome. For that purpose, mean size and PDI variations were monitored over a 20-day storage period at 4 °C ( Figure 8 ); considerable changes in these domains reveal signs of either aggregation or membrane rupture [ 62 ]. During this time, the MPELs size presented minimal shifts from the day 1 value (D 0 = 105.9 ± 4 nm; D 20 = 106.7 ± 3 nm), suggesting that these should remain stable in long-term storage.…”
Section: Resultsmentioning
confidence: 99%
“…A stability study was performed to determine whether these magneto-plasmonic elastic liposomes satisfy the requirements for commercial and clinical outcome. For that purpose, mean size and PDI variations were monitored over a 20-day storage period at 4 °C ( Figure 8 ); considerable changes in these domains reveal signs of either aggregation or membrane rupture [ 62 ]. During this time, the MPELs size presented minimal shifts from the day 1 value (D 0 = 105.9 ± 4 nm; D 20 = 106.7 ± 3 nm), suggesting that these should remain stable in long-term storage.…”
Section: Resultsmentioning
confidence: 99%
“…Regarding the zeta potential values, both NLCs are negatively charged. Even if NLC1 are composed of non-ionic surfactants, the presence of residual free fatty acids in soy lecithin (e.g., phosphatidic acid) [ 22 ] or poloxamer (e.g., resultant from polymer hydrolysis) confers a negative net charge to the formulations [ 51 ]. NLC2 composition includes an anionic surfactant, DOSS, which justifies the significantly lower (more negative) zeta potential values obtained for NLC2 than NLC1.…”
Section: Resultsmentioning
confidence: 99%
“…Existing antitumor chemotherapy still suffers from two major limitations. 3 The first is that conventional chemotherapeutic agents are not selective for cancer tissues, resulting in unwanted side effects. The second is that cancer cells have proved to be resistant to multiple drugs.…”
Section: Introductionmentioning
confidence: 99%